Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00585260 · ClinicalTrials.gov registry record · Early Phase 1
Mannitol Bronchoprovocation Challenge Ancillary Study/ACRN
A Early Phase 1 study, sponsored by University of Wisconsin, Madison.
- Completed
- Registry status
- Early Phase 1
- Development phase
- 66
- Enrollment target
NCT00585260 is a Early Phase 1 study that has completed, run by University of Wisconsin, Madison. The registered enrollment target is 66 participants.
The verdict
NCT00585260, a Early Phase 1 study, has completed, sponsored by University of Wisconsin, Madison.
- COMPLETED
- Registry status
- Early Phase 1
- Development phase
- 66 participants
- Enrollment target
Study Summary
This is an ancillary study conducted as part of the BASALT trial \[NCT00495157\]. The overall hypotheses are: 1) an indirect airway challenge procedure using mannitol can safely characterize asthma phenotypes, predict asthma control and exacerbations, predict responses to interventions, and perform more specifically than a direct methacholine challenge and; 2) PX27 pore function in whole blood correlates with measures of airway hyperresponsiveness induced by methacholine and/or mannitol challenges
Interventions
- DRUG mannitol
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 66 participants |
| Start Date | 2007-12 |
| Est. Completion | 2010-02-16 |
| Phase | Early Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00585260
The ClinicalTrials.gov registry entry for NCT00585260 describes a study currently listed as completed, categorized as Early Phase 1. The registered enrollment target is 66 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Wisconsin, Madison, which has 1,039 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which mannitol is the first listed.
NCT00585260 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00585260 about?
NCT00585260 is a clinical study titled "Mannitol Bronchoprovocation Challenge Ancillary Study/ACRN". This is an ancillary study conducted as part of the BASALT trial \[NCT00495157\]. The overall hypotheses are: 1) an indirect airway challenge procedure using mannitol can safely characterize asthma phenotypes, predict asthma control and exacerbations, predict responses to interventions, and perform...
What is the current status of trial NCT00585260?
This trial is currently completed. It is a Early Phase 1 study. The enrollment target is 66 participants. The study started on 2007-12. Estimated completion is 2010-02-16.
What interventions are being tested in trial NCT00585260?
The interventions under investigation include: mannitol (DRUG).
Who is sponsoring clinical trial NCT00585260?
This trial is sponsored by University of Wisconsin, Madison, which has 1,039 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.